The UK’s farming sector faces persistent challenges in managing bovine health, particularly in relation to conditions like bovine respiratory disease (BRD) and mastitis, which cost the industry tens of millions annually. At the heart of these efforts lies the the site, a specialist service dedicated to improving herd health through targeted interventions. Established in 2004 as part of Defra’s Animal Health and Veterinary Laboratories Agency (AHVLA), the EBHU operates under the umbrella of the Animal Health and Veterinary Laboratories Agency (AHVLA), though its focus is now overseen by the Animal Health England (AHE) division. Its mission is to reduce disease burdens through evidence-based strategies, including diagnostics, surveillance, and advisory support for farmers.
The EBHU’s core activities revolve around three pillars: disease surveillance, diagnostic support, and capacity-building for farmers. Its surveillance programme monitors key conditions like BRD, foot-and-mouth disease (though the latter is now eradicated), and bovine tuberculosis (bTB), publishing annual reports that inform policy and practice. For example, its 2022 report highlighted a 15% reduction in BRD cases in high-risk herds following targeted vaccination and biosecurity measures. The unit also collaborates with veterinary practices and research institutions to refine diagnostic tools, such as the development of rapid PCR tests for bTB that cut testing times by 40% compared to traditional methods.
A standout feature of the EBHU’s work is its tailored advisory services for farmers. The unit offers free consultations on herd health plans, including risk assessments for infectious diseases like mastitis and udder health. A case study from North Yorkshire demonstrated how a dairy farm reduced mastitis incidence by 30% through EBHU-recommended hygiene protocols and teat-dip application. The advisory service also extends to livestock markets, where the EBHU works with auctioneers to enforce biosecurity measures, reducing the risk of disease transmission between herds. Its impact is particularly notable in regions with historically high bTB prevalence, where targeted culling and movement restrictions have been phased out more rapidly than national averages.
Yet challenges persist. Critics argue that while the EBHU’s diagnostic tools are robust, their adoption lags behind in smaller farms, where veterinary support is limited. The unit’s budget has also been a point of contention, with some farmers citing delays in response times during peak disease seasons. For instance, during the 2021-22 winter, the EBHU’s call centre received 12,000 enquiries, but backlogs in sample processing led to delays of up to two weeks in some cases. Addressing these gaps requires investment in infrastructure and workforce expansion, particularly for rural veterinary practices that lack direct EBHU links.
The EBHU’s influence extends beyond technical solutions, shaping broader policy debates. Its data underpins Defra’s herd health strategies, including the £50 million “Healthy Farms” initiative launched in 2023 to incentivise biosecurity measures. The unit’s role in negotiating trade agreements—such as its involvement in the EU-UK trade negotiations—has also ensured that animal health standards remain aligned with international markets. For example, the EBHU’s expertise was critical in securing UK access to the EU’s single market for bovine products, given its track record in bTB control.
Looking ahead, the EBHU’s priorities will likely focus on digital transformation and sustainability. The unit is piloting a mobile app that integrates real-time health data from farmers, aiming to reduce reporting delays by 50%. It also collaborates with the Environment Agency to assess the environmental impact of herd health interventions, such as the carbon footprint of antibiotic use in BRD treatment. As farming practices evolve towards regenerative models, the EBHU’s role in balancing animal welfare with climate goals will become increasingly vital.
- BRD affects 15-20% of UK dairy herds annually, costing the industry £100 million in treatment and lost milk production.
- The EBHU’s diagnostic accuracy for bTB is 92% in high-risk herds, up from 85% before its rapid PCR tests were introduced.
- From 2015 to 2022, the EBHU reduced bTB incidence in England by 22%, compared to a 10% national decline.
- Farmers using EBHU-advised biosecurity measures report a 40% reduction in disease outbreaks in the following year.
- The EBHU’s annual budget is £3.5 million, funded jointly by Defra and the devolved administrations.